Mesh-Augmented Ventral Hernia Repair Despite Iatrogenic -Peritonitis Due to Progressive Pneumoperitoneum: A Case Report.
Abstract
[INTRODUCTION] Loss-of-domain in large incisional hernia needs to be addressed by mesh-augmented repair combined with a combination of component separation techniques: progressive pneumoperitoneum (PPP) and chemical component separation with botulinum toxin A. In this case report, successful management of an iatrogenic peritonitis caused by PPP with nevertheless definitive treatment of a giant loss-of-domain ventral hernia is presented.
[CASE PRESENTATION] A female patient with M1-3W3 recurrent incisional hernia with a loss-of-domain of 47% was prepared for definitive ventral hernia repair by chemical component separation with botulinum toxin A-infiltration and PPP via an intraperitoneally placed central venous catheter. A significant increase of inflammatory markers was found after 28 days. An emergency CT scan was performed, which showed the PPP and perihepatic/perisplenic contrast-enhancing fluid collections. Exploratory laparoscopy and laparotomy revealed no bowel perforation but fibrinous peritonitis due to an iatrogenic PPP-catheter-associated peritonitis. Despite the fibrinous peritonitis, we decided to proceed with definitive ventral hernia repair (Rives-Stoppa-Sublay-Herniotomy with transversus abdominis release (left) and anterior component separation (right), 42 × 30 cm permanent polypropylene mesh). Initial calculated antibiotic treatment was performed with piperacillin/tazobactam. Microbiologic examinations revealed in the intraoperative specimens on postoperative day 1 and the antibiotic treatment was changed to intravenous flucloxacillin for 14 days after surgery. The further hospital stay was uneventful and the patient was discharged on the 20th postoperative day.
[CONCLUSIONS] The presented case demonstrates the possibilities in complex ventral hernia repair to achieve a satisfying outcome for the patients. Even in cases with infectious complications, a single-stage procedure might be performed safely and a complete reconstruction of the abdominal wall might be achieved. The risk of chronic mesh infection in contaminated situations, especially during the presence of , remains uncertain and has to be weighed against possible benefits.
[CASE PRESENTATION] A female patient with M1-3W3 recurrent incisional hernia with a loss-of-domain of 47% was prepared for definitive ventral hernia repair by chemical component separation with botulinum toxin A-infiltration and PPP via an intraperitoneally placed central venous catheter. A significant increase of inflammatory markers was found after 28 days. An emergency CT scan was performed, which showed the PPP and perihepatic/perisplenic contrast-enhancing fluid collections. Exploratory laparoscopy and laparotomy revealed no bowel perforation but fibrinous peritonitis due to an iatrogenic PPP-catheter-associated peritonitis. Despite the fibrinous peritonitis, we decided to proceed with definitive ventral hernia repair (Rives-Stoppa-Sublay-Herniotomy with transversus abdominis release (left) and anterior component separation (right), 42 × 30 cm permanent polypropylene mesh). Initial calculated antibiotic treatment was performed with piperacillin/tazobactam. Microbiologic examinations revealed in the intraoperative specimens on postoperative day 1 and the antibiotic treatment was changed to intravenous flucloxacillin for 14 days after surgery. The further hospital stay was uneventful and the patient was discharged on the 20th postoperative day.
[CONCLUSIONS] The presented case demonstrates the possibilities in complex ventral hernia repair to achieve a satisfying outcome for the patients. Even in cases with infectious complications, a single-stage procedure might be performed safely and a complete reconstruction of the abdominal wall might be achieved. The risk of chronic mesh infection in contaminated situations, especially during the presence of , remains uncertain and has to be weighed against possible benefits.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | PPP
→ progressive pneumoperitoneum
|
scispacy | 1 | ||
| 해부 | bowel
|
scispacy | 1 | ||
| 해부 | fibrinous
|
scispacy | 1 | ||
| 해부 | anterior
|
scispacy | 1 | ||
| 합병증 | infection
|
감염 | dict | 1 | |
| 합병증 | contrast-enhancing fluid
|
scispacy | 1 | ||
| 재료 | polypropylene mesh
|
메쉬 | dict | 1 | |
| 약물 | PPP
→ progressive pneumoperitoneum
|
scispacy | 1 | ||
| 약물 | piperacillin/tazobactam
|
C0250480
piperacillin-tazobactam combination
|
scispacy | 1 | |
| 약물 | flucloxacillin
|
C0016267
floxacillin
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] Loss-of-domain
|
scispacy | 1 | ||
| 약물 | intravenous flucloxacillin for 14
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | hernia
|
C0019270
Hernia
|
scispacy | 1 | |
| 질환 | peritonitis
|
C0031154
Peritonitis
|
scispacy | 1 | |
| 질환 | fibrinous peritonitis
|
C0267753
Fibrinous peritonitis
|
scispacy | 1 | |
| 질환 | ventral hernia
|
C0019326
Ventral Hernia
|
scispacy | 1 | |
| 질환 | infectious complications
|
scispacy | 1 | ||
| 질환 | chronic mesh infection
|
C0151317
Chronic Infection
|
scispacy | 1 | |
| 기타 | Mesh-Augmented
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | M1-3W3
|
scispacy | 1 | ||
| 기타 | PPP
→ progressive pneumoperitoneum
|
scispacy | 1 | ||
| 기타 | transversus abdominis
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | abdominal wall
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.